David M. Tanen's most recent trade in Kronos Bio Inc was a trade of 471,230 Common Stock done at an average price of $0.6 . Disclosure was reported to the exchange on June 20, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Kronos Bio Inc | David M. Tanen | Director | 20 Jun 2025 | 471,230 | 0 | - | 0.6 | 268,601 | Common Stock | |
| Kronos Bio Inc | David M. Tanen | Director | 20 Jun 2025 | 363,428 | 0 | - | 0.6 | 207,154 | Common Stock | |
| Kronos Bio Inc | David M. Tanen | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 Jun 2025 | 85,608 | 0 | - | - | Stock Option (Right to Buy) | |
| Kronos Bio Inc | David M. Tanen | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 Jun 2025 | 34,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Kronos Bio Inc | David M. Tanen | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 Jun 2025 | 34,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Kronos Bio Inc | David M. Tanen | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 Jun 2025 | 34,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Kronos Bio Inc | David M. Tanen | Director | 20 Jun 2025 | 26,375 | 0 | - | 0.6 | 15,034 | Common Stock | |
| Kronos Bio Inc | David M. Tanen | Director | 20 Jun 2025 | 26,375 | 0 | - | 0.6 | 15,034 | Common Stock | |
| Kronos Bio Inc | David M. Tanen | Director | 20 Jun 2025 | 26,375 | 0 | - | 0.6 | 15,034 | Common Stock | |
| Kronos Bio Inc | David M. Tanen | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 Jun 2025 | 20,600 | 0 | - | - | Stock Option (Right to Buy) | |
| Kronos Bio Inc | David M. Tanen | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 Jun 2025 | 19,892 | 0 | - | - | Stock Option (Right to Buy) | |
| Kronos Bio Inc | David M. Tanen | Director | 25 Jun 2024 | 34,000 | 34,000 | - | - | Stock Option (Right to Buy) | ||
| Kronos Bio Inc | David M. Tanen | Director | 22 Jun 2023 | 34,000 | 34,000 | - | - | Stock Option (Right to Buy) | ||
| Kronos Bio Inc | David M. Tanen | Director | 22 Jun 2022 | 34,000 | 34,000 | - | - | Stock Option (Right to Buy) | ||
| Kronos Bio Inc | David M. Tanen | Director | 22 Jun 2021 | 20,600 | 20,600 | - | - | Stock Option (Right to Buy) | ||
| Kronos Bio Inc | David M. Tanen | Director | 14 Oct 2020 | 233,405 | 365,280 | - | - | Common Stock | ||
| Kronos Bio Inc | David M. Tanen | Director | 14 Oct 2020 | 231,553 | 363,428 | - | - | Common Stock | ||
| Kronos Bio Inc | David M. Tanen | Director | 14 Oct 2020 | 221,237 | 0 | - | - | Series Seed Preferred Stock | ||
| Kronos Bio Inc | David M. Tanen | Director | 14 Oct 2020 | 219,482 | 0 | - | - | Series Seed Preferred Stock | ||
| Kronos Bio Inc | David M. Tanen | Director | 14 Oct 2020 | 68,831 | 434,111 | - | - | Common Stock | ||
| Kronos Bio Inc | David M. Tanen | Director | 14 Oct 2020 | 65,243 | 0 | - | - | Series A Preferred Stock | ||
| Kronos Bio Inc | David M. Tanen | Director | 14 Oct 2020 | 37,119 | 471,230 | - | 16.2 | 599,472 | Common Stock |